The standard PT-141 dose is 1.75 mg injected under the skin at least 45 minutes before sexual activity. Learn about research dosing, nasal spray, and safety.
The standard PT-141 dose is 1.75 mg, injected under the skin of the abdomen or thigh at least 45 minutes before anticipated sexual activity. That is the only dose approved by the FDA, and it is limited to one dose in any 24-hour period and no more than eight doses per month. PT-141 is the research name for bremelanotide, the active ingredient in the prescription drug Vyleesi.
PT-141 is not a generic erectile dysfunction drug, and it is not approved for men. The FDA approved Vyleesi in 2019 for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Doses used in research or sold as research chemicals fall outside that label and carry additional risk.
PT-141 Dose and the FDA-Approved Label
The approved PT-141 dose is fixed at 1.75 mg per subcutaneous injection. There is no approved oral, sublingual, or nasal version of bremelanotide in the United States.
- Route: Subcutaneous injection into the abdomen or thigh.
- Timing: At least 45 minutes before sexual activity.
- Frequency: No more than one dose in 24 hours and no more than eight doses per month.
- Population: Premenopausal women with acquired, generalized HSDD.
Taking more than the labeled dose does not improve results and increases the risk of nausea, flushing, and blood pressure changes. The FDA label specifically warns against exceeding eight doses per month because of the risk of focal hyperpigmentation, including darkening of the gums, face, and breasts.
PT-141 Dose Comparison: Injection, Nasal Spray, and Research Use
The difference between pt-141 nasal spray vs injection comes down to absorption, consistency, and regulatory status. Only the injection has been reviewed by the FDA for safety and effectiveness.
| Form | Typical amount studied or approved | Onset | Regulatory status |
|---|---|---|---|
| Subcutaneous injection (Vyleesi) | 1.75 mg | About 45 minutes | FDA approved for premenopausal women with HSDD |
| Nasal spray (investigational) | 7.5 mg to 12.5 mg in older trials | Roughly 30 to 60 minutes | Not FDA approved; no standard product |
| Research chemical injection | Varies; often 1 to 2 mg | Variable | Not FDA approved; purity and sterility not guaranteed |
| Off-label use in men | 1.75 mg to 2 mg in small studies | About 45 to 90 minutes | Not FDA approved for men |
Nasal bremelanotide was studied in early clinical trials at doses of 7.5 mg and 12.5 mg, but those programs were discontinued. No nasal spray version of PT-141 has received FDA approval. A compounded or research nasal spray may contain unknown amounts of the drug and inconsistent particle sizes, so the effective dose can vary widely from one bottle to the next.
PT-141 Dosage for Women: What the Label Approves
The pt-141 dosage for women is 1.75 mg injected subcutaneously, as needed, before sexual activity. The label does not include a daily maintenance dose or a dose that builds up over time.
In the clinical trials that led to approval, participants used the 1.75 mg dose and reported improvements in desire and distress scores. The most common side effects were nausea (about 40 percent of users), flushing, headache, and injection site reactions. Nausea usually improves with repeated use, but some women stop treatment because of it.
Bremelanotide is contraindicated in women with uncontrolled high blood pressure or known cardiovascular disease. It can cause a temporary rise in blood pressure, so a healthcare professional should review your history before prescribing it.
How Long PT-141 Lasts and When It Starts Working
A common question is how long does pt-141 last after a single injection. Bremelanotide reaches peak blood levels in about one hour, and its half-life is roughly 2.7 hours. Most users report effects lasting between two and six hours.
Another frequent search is pt-141 how long does it take to work. The label instructs users to inject at least 45 minutes before anticipated sexual activity. Some people notice effects sooner, while others need closer to 90 minutes.
Timing matters more than dose escalation. If the 1.75 mg dose does not produce the desired effect, increasing the amount on your own is not recommended. Talk with a prescriber about whether a different treatment option makes more sense.
Safety, Side Effects, and Sourcing
PT-141 is a prescription medication, not a supplement. If you are wondering where to buy pt-141, the only FDA-approved route in the United States is a prescription for Vyleesi from a licensed pharmacy.
Research chemical vendors often sell PT-141 as a lyophilized powder or a pre-mixed nasal spray. These products are not reviewed for purity, sterility, or actual drug content. Injecting a non-sterile product can cause infections, abscesses, and systemic reactions.
Common side effects of bremelanotide include:
- Nausea and vomiting
- Flushing and headache
- Injection site pain, bruising, or swelling
- Transient increases in blood pressure
- Focal hyperpigmentation with frequent use
Talk to a healthcare professional if you take blood pressure medications, have kidney or liver disease, or are pregnant or breastfeeding. The bottom line is that the approved PT-141 dose is 1.75 mg injected subcutaneously, no more than once per day and eight times per month. Any other dose, route, or product is experimental and should be approached with caution.
Frequently Asked Questions
What is the recommended PT-141 dose?
The FDA-approved PT-141 dose is 1.75 mg injected subcutaneously into the abdomen or thigh. It should be taken at least 45 minutes before sexual activity, no more than once in 24 hours, and no more than eight times per month. This dose is approved only for premenopausal women with acquired, generalized hypoactive sexual desire disorder.
Can I use a PT-141 nasal spray instead of injections?
No PT-141 nasal spray is FDA-approved in the United States. Nasal bremelanotide was studied in older clinical trials at doses of 7.5 mg to 12.5 mg, but those programs were discontinued. Compounded or research nasal sprays are not standardized, so the actual dose delivered can vary and sterility is not guaranteed.
How long does PT-141 take to start working and how long does it last?
PT-141 is injected at least 45 minutes before sexual activity, and many users notice effects within one hour. The half-life of bremelanotide is about 2.7 hours, and reported effects typically last two to six hours. Individual responses vary, so timing may differ from person to person.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.